<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PFE
Pfizer
$
()


  • Pfizer sued by state of Kansas over COVID-19 vaccine, Reuters reports

    6/18/2024 - 06:11am
  • Pfizer announces overall survival data from MagnetisMM-3 study of Elrexfio

    6/14/2024 - 05:25am
  • Pfizer DMD gene therapy miss paves way for Sarepta, Solid Biosciences, says Citi

    6/13/2024 - 13:18pm
  • Sarepta rises as Pfizer ‘disappointing’ DMD results remove competitor overhang

    6/13/2024 - 10:42am
  • Pfizer failure eliminates DMD competitor for Sarepta, says Baird

    6/13/2024 - 10:14am
  • Pfizer's 'disappointing' Phase 3 results positive for Sarepta, says Mizuho

    6/13/2024 - 10:06am
  • Pfizer failure removes overhang for Sarepta, says Barclays

    6/13/2024 - 05:41am
  • Pfizer says Phase 3 CIFFREO study did not meet primary endpoint

    6/12/2024 - 16:30pm
  • GSK starts process for appeal of recent Delaware Daubert ruling

    6/10/2024 - 17:37pm
  • Pfizer 'very confident we will make our numbers'

    6/10/2024 - 11:51am
  • Jefferies biotech analysts holds an analyst/industry conference call

    6/7/2024 - 11:28am
  • Relay teams with with Pfizer for RLY-2608/atirmociclib combo evaluation for BC

    6/5/2024 - 16:13pm
  • Olema Oncology price target raised by $9 at Oppenheimer, here's why

    6/4/2024 - 14:10pm
  • Pfizer presents detailed data from Phase 3 ECHELON-3 study

    6/2/2024 - 06:54am
  • Takeda, Pfizer announce four-year results from Phase 3 HD21 trial

    6/2/2024 - 06:51am
dynamic_feed Breaking News